---
figid: PMC4807992__oncotarget-07-0193-g001
figlink: /pmc/articles/PMC4807992/figure/F1/
number: F1
caption: The transcriptional and non-transcriptional models of androgen action in
  target cells are depicted. Upon ligand binding, cytoplasmic AR dimerizes and translocates
  into nuclei of target cells, where it activates gene transcription [, , , ]. In
  the extra-nuclear compartment of target cells, ligand-bound AR recruits and activates
  various signaling effectors, including Src, PI3-K, β1-integrin and filamin A. Stimulation
  of target cells with androgens triggers cell cycle progression through AR/Src/PI3-K
  complex assembly [, ]. Androgens also induce the assembly of AR/filamin A/β1-integrin
  complex. This complex activates Rac, thereby inducing motility or differentiation
  in target cells [, ]. Under certain conditions, the androgen-triggered AR/filamin
  A complex activates the Rac/dual-specificity tyrosine-phosphorylation regulated
  kinase 1B (DYRK1B) pathway, leading to p27 Ser10 phosphorylation and p27 stabilization.
  Reversible quiescence of target cells follows []. By this mechanism, androgens might
  offset the growth-promoting functions driven by oncogenic Ras [] or growth factors
  (unpublished results).
pmcid: PMC4807992
papertitle: 'Prostate cancer stem cells: the role of androgen and estrogen receptors.'
reftext: Erika Di Zazzo, et al. Oncotarget. 2016 Jan 5;7(1):193-208.
pmc_ranked_result_index: '32359'
pathway_score: 0.9480961
filename: oncotarget-07-0193-g001.jpg
figtitle: 'Prostate cancer stem cells: the role of androgen and estrogen receptors'
year: '2016'
organisms: Homo sapiens
ndex: 14c2760f-defa-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4807992__oncotarget-07-0193-g001.html
  '@type': Dataset
  description: The transcriptional and non-transcriptional models of androgen action
    in target cells are depicted. Upon ligand binding, cytoplasmic AR dimerizes and
    translocates into nuclei of target cells, where it activates gene transcription
    [, , , ]. In the extra-nuclear compartment of target cells, ligand-bound AR recruits
    and activates various signaling effectors, including Src, PI3-K, β1-integrin and
    filamin A. Stimulation of target cells with androgens triggers cell cycle progression
    through AR/Src/PI3-K complex assembly [, ]. Androgens also induce the assembly
    of AR/filamin A/β1-integrin complex. This complex activates Rac, thereby inducing
    motility or differentiation in target cells [, ]. Under certain conditions, the
    androgen-triggered AR/filamin A complex activates the Rac/dual-specificity tyrosine-phosphorylation
    regulated kinase 1B (DYRK1B) pathway, leading to p27 Ser10 phosphorylation and
    p27 stabilization. Reversible quiescence of target cells follows []. By this mechanism,
    androgens might offset the growth-promoting functions driven by oncogenic Ras
    [] or growth factors (unpublished results).
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - AKT2
  - AKT1
  - AR
  - NRAS
  - STAB2
  - PIK3CA
  - PIK3R6
  - PIK3R5
  - AKT3
  - RAC1
  - SRC
  - PIK3CB
  - CCND1
  - PIK3R4
  - DYRK1B
  - HRAS
  - KRAS
  - PIK3CD
  - MAP2K1
  - MAP2K2
  - MAPK1
  - MAPK3
  - L1CAM
  - PIK3R3
  - PIK3CG
  - Androgen
  - Cancer
genes:
- word: akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: AR
  symbol: AR
  source: hgnc_symbol
  hgnc_symbol: AR
  entrez: '367'
- word: ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: fell
  symbol: FELL
  source: hgnc_alias_symbol
  hgnc_symbol: STAB2
  entrez: '55576'
- word: PI3-K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: PI3-K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: PI3-K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: Rac1
  symbol: RAC1
  source: hgnc_symbol
  hgnc_symbol: RAC1
  entrez: '5879'
- word: src
  symbol: SRC
  source: hgnc_symbol
  hgnc_symbol: SRC
  entrez: '6714'
- word: PI3-K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: CyclinD1
  symbol: Cyclin-D1
  source: bioentities_symbol
  hgnc_symbol: CCND1
  entrez: '595'
- word: PI3-K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: DYRK1B
  symbol: DYRK1B
  source: hgnc_symbol
  hgnc_symbol: DYRK1B
  entrez: '9149'
- word: ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: PI3-K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: erk
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: erk
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: S10
  symbol: S10
  source: hgnc_prev_symbol
  hgnc_symbol: L1CAM
  entrez: '3897'
- word: PI3-K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: PI3-K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
chemicals:
- word: Androgen
  source: MESH
  identifier: D000728
diseases:
- word: Cancer
  source: ''
  identifier: ''
figid_alias: PMC4807992__F1
redirect_from: /figures/PMC4807992__F1
figtype: Figure
---
